Literature DB >> 9184276

Clinical characteristics related to methotrexate-induced pancytopenia.

Y Ohosone, Y Okano, H Kameda, N Hama, T Mimori, M Akizuki, Y Ikeda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9184276     DOI： 10.1007/BF02238974

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  10 in total

1.  Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprim-sulfamethoxazole treatment.

Authors:  M Maricic; M Davis; E P Gall
Journal:  Arthritis Rheum       Date:  1986-01

2.  Fatal interaction between methotrexate and naproxen.

Authors:  R R Singh; A N Malaviya; J N Pandey; J S Guleria
Journal:  Lancet       Date:  1986-06-14       Impact factor: 79.321

3.  Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritis.

Authors:  R Omdal; L Gøransson; H Bergrem
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

4.  Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression.

Authors:  P S Hanrahan; G A Scrivens; A S Russell
Journal:  Br J Rheumatol       Date:  1989-04

5.  Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis.

Authors:  S Gutierrez-Ureña; J F Molina; C O García; M L Cuéllar; L R Espinoza
Journal:  Arthritis Rheum       Date:  1996-02

6.  Pancytopenia after accidental overdose of methotrexate. A complication of low-dose therapy for rheumatoid arthritis.

Authors:  M A Brown; A B Corrigan
Journal:  Med J Aust       Date:  1991-10-07       Impact factor: 7.738

7.  Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis.

Authors:  S K MacKinnon; G Starkebaum; R F Willkens
Journal:  Semin Arthritis Rheum       Date:  1985-11       Impact factor: 5.532

8.  Pancytopenia associated with low dose methotrexate therapy. A regional survey.

Authors:  A al-Awadhi; P Dale; R J McKendry
Journal:  J Rheumatol       Date:  1993-07       Impact factor: 4.666

9.  The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. Rheumatoid Arthritis Clinical Trial Archive Group.

Authors: 
Journal:  J Rheumatol       Date:  1995-02       Impact factor: 4.666

10.  Pancytopenia related eosinophilia in rheumatoid arthritis: a specific methotrexate phenomenon?

Authors:  G A Bruyn; E Velthuysen; P Joosten; P M Houtman
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666
  10 in total
  3 in total

1.  Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis.

Authors:  Hideto Kameda; Ayumi Okuyama; Jun-Ichi Tamaru; Shinji Itoyama; Atsushi Iizuka; Tsutomu Takeuchi
Journal:  Clin Rheumatol       Date:  2007-01-03       Impact factor: 2.980

2.  Effects of a biologic agent in a patient with rheumatoid arthritis after treatment for methotrexate-associated B-cell lymphoma: a case report.

Authors:  Takeshi Kuroda; Hiroe Sato; Takeshi Nakatsue; Yoko Wada; Shuichi Murakami; Masaaki Nakano; Ichiei Narita
Journal:  BMC Res Notes       Date:  2014-04-11

3.  Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.

Authors:  Shunsuke Mori; Michihiro Hidaka; Toshiro Kawakita; Toshihiko Hidaka; Hiroyuki Tsuda; Tamami Yoshitama; Kiyoshi Migita; Yukitaka Ueki
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.